HTG Molecular Diagnostics (NASDAQ:HTGM) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
HTG Molecular Diagnostics missed estimated earnings by 14.08%, reporting an EPS of $-0.81 versus an estimate of $-0.71.
Revenue was down $251.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.1 which was followed by a 7.55% drop in the share price the next day.
Here's a look at HTG Molecular Diagnostics's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.59 | -0.66 | -0.77 | -1.02 |
| EPS Actual | -0.69 | -0.60 | -0.65 | -0.80 |
| Revenue Estimate | 2.97M | 2.65M | 2.13M | 1.69M |
| Revenue Actual | 2.88M | 2.52M | 2.07M | 1.44M |
To track all earnings releases for HTG Molecular Diagnostics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
